Φιλτράρισμα ανά Last updated date SelectΜετάΠρινFrom - To Date Ημερομηνία λήξης This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Αποτελέσματα (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank European Medicines Agency: Committee for Medicinal Products for Human Use, 1-3 June 2004 4 Ιούνιος 2004Press releaseHumanMedicines EMEA announces composition of its scientific committees 1 Ιούνιος 2004Press release CHMP elects new chair and vice-chair at its first meeting 1 Ιούνιος 2004Press release New Management Board elects its chairman and approves composition of new scientific committees 25 Μάιος 2004Press releaseCorporate SONOVUE (1) (sulphur hexafluoride): New contraindication in patients with heart disease. Restriction of use to non-cardiac imaging. 20 Μάιος 2004News Committee for Orphan Medicinal Products: May 2004 meeting 17 Μάιος 2004Press releaseHumanRare diseases Committee for medicinal products for veterinary use: Meeting of 11 to 13 May 2004 14 Μάιος 2004Press releaseVeterinary Procedural announcements 7 Μάιος 2004Press release New pharmaceutical legislation enters into force on 20 May 2004 3 Μάιος 2004Press release European Medicines Agency Public Statement on the lifting of the suspension of the marketing authorisation for Tolcapone (Tasmar) 29 Απρίλιος 2004NewsMedicines 1 … 344 345 346 347 348 Page 348 of 384 349 350 351 352 … 384
European Medicines Agency: Committee for Medicinal Products for Human Use, 1-3 June 2004 4 Ιούνιος 2004Press releaseHumanMedicines
New Management Board elects its chairman and approves composition of new scientific committees 25 Μάιος 2004Press releaseCorporate
SONOVUE (1) (sulphur hexafluoride): New contraindication in patients with heart disease. Restriction of use to non-cardiac imaging. 20 Μάιος 2004News
Committee for Orphan Medicinal Products: May 2004 meeting 17 Μάιος 2004Press releaseHumanRare diseases
Committee for medicinal products for veterinary use: Meeting of 11 to 13 May 2004 14 Μάιος 2004Press releaseVeterinary
European Medicines Agency Public Statement on the lifting of the suspension of the marketing authorisation for Tolcapone (Tasmar) 29 Απρίλιος 2004NewsMedicines